Skip to main content
Women's Health

Understanding IVF and Ovarian Hyperstimulation Syndrome

KiranAugust 28, 20255 min read

Key Highlights

  • Ovarian Hyperstimulation Syndrome (OHSS) is a condition that can occur due to hormonal medications used in fertility treatments.

  • It is characterized by enlarged ovaries and fluid leakage into the abdomen.

  • Symptoms range from mild discomfort to severe pain, bloating, nausea, and vomiting.

  • Early diagnosis and management are crucial to prevent complications.

  • Understanding the causes, symptoms, and treatment options is vital for women undergoing fertility treatments.

Introduction

Ovarian hyperstimulation syndrome (OHSS) is a potential complication associated with fertility treatments, particularly in vitro fertilization (IVF).

This condition arises when medications used to stimulate ovulation cause the ovaries to become enlarged and leak fluid into the abdomen.
Mild OHSS occurs in as many as 33% of women undergoing IVF. Moderate to severe cases occur in 1%.
While OHSS is more common in women undergoing IVF, it can also occur with other fertility treatments. Let’s explore the connection between IVF and this syndrome.

The Connection Between Hormones and OHSS

Hormones play a critical role in regulating the menstrual cycle and ovulation. In fertility treatments, medications containing hormones like follicle-stimulating hormone (FSH) and luteinizing hormone (LH) are administered to stimulate the ovaries to produce multiple eggs.
However, this hormonal stimulation can sometimes lead to an excessive response, resulting in OHSS. The ovaries might become significantly enlarged, and fluid can leak from the blood vessels within them, accumulating in the abdominal cavity and causing a range of uncomfortable symptoms.

Defining Ovarian Hyperstimulation Syndrome

Ovarian Hyperstimulation Syndrome is a potential complication of fertility treatments like in vitro fertilization.
It arises from the overstimulation of the ovaries, leading to symptoms ranging from mild discomfort to severe complications. Symptoms of OHSS is characterized by:

  • Weight gain

  • Abdominal pain

  • Blood clots (3)

  • Decreased urination

  • Diarrhea

  • Fluid accumulation in the abdomen

  • Fluid accumulation in the chest

Monitoring hormone levels and undergoing ultrasound examinations are crucial in assessing the severity of symptoms and determining appropriate treatment options. OHSS can be distressing, but early detection and proper management can help mitigate risks.

The Role of Hormones in OHSS Development

Hormonal medications used in fertility treatments aim to stimulate the ovaries to produce multiple mature eggs. Human chorionic gonadotropin (hCG), a hormone naturally produced during pregnancy, is often used as a “trigger shot” to induce ovulation.
While hCG is crucial for ovulation, it can also contribute to hyperstimulated ovaries. (2) This hormone increases vascular permeability, meaning it allows fluids and proteins to pass through blood vessel walls more easily.

In OHSS, this heightened permeability results in fluid leaking from the blood vessels in the ovaries, leading to their enlargement and the accumulation of fluid in the abdomen.

What Genetic Factors Can Lead to OHSS?

Factors that can increase the risk of developing OHSS include a history of PCOS, young age, low body weight, high doses of fertility medications, and a history of previous OHSS episodes.
Being aware of these risk factors can help healthcare providers tailor treatment plans to minimize the likelihood of developing this condition.

PCOS and OHSS

Polycystic ovary syndrome (PCOS), a hormonal disorder affecting women, can also increase the risk of hyperstimulated ovaries. Women with PCOS often have multiple small cysts in their ovaries and may be more sensitive to fertility medications, making them prone to developing this complication.

The incidence of OHSS in PCOS patients increased significantly up to 13.9X higher than in patients without PCOS.
Understanding these primary causes is essential for healthcare professionals to develop personalized treatment strategies and minimize OHSS risk in women undergoing fertility treatments.

Symptoms and Diagnosis of OHSS

Early recognition of OHSS is crucial to prevent its progression into a severe condition. Common early symptoms include:

  • Mild to moderate abdominal pain

  • Abdominal bloating or increased waist size

  • Nausea

  • Vomiting

  • Diarrhea

  • Tenderness in the area of ovaries

If you experience any of these symptoms, inform your healthcare provider promptly.
If you become pregnant during that cycle, OHSS symptoms might persist or worsen. It’s vital to remain vigilant and report any unusual symptoms to your healthcare provider throughout your fertility treatment.

Treating and Managing OHSS

The treatment for overactive ovaries depends on its severity. Mild cases often resolve independently with careful monitoring, rest, and over-the-counter pain relievers.

Staying hydrated is crucial, and doctors might recommend drinking electrolyte solutions to maintain fluid balance.

For moderate to severe cases, hospitalization may be necessary. Treatment focuses on relieving symptoms, preventing complications, and supporting bodily functions.
This can involve intravenous fluid administration, medication to relieve pain and reduce fluid in the abdomen, and close monitoring of vital signs.

Medical Treatments for OHSS

For mild cases, pain relievers and close monitoring might suffice. (6)

However, moderate to severe OHSS often requires hospitalization. Intravenous fluids are commonly administered to correct dehydration and electrolyte imbalances, alleviating symptoms and supporting kidney function.

Medications like dopamine agonists can be used to reduce vascular endothelial growth factor (VEGF) production. VEGF is a protein that promotes blood vessel formation and increases permeability; reducing its levels can help minimize fluid leakage from blood vessels in the ovaries, thus reducing swelling and discomfort.

Citations

Recommended For You

PCOS HRT vs Ozempic for Menopausal Weight Management

HRT vs Ozempic for Menopausal Weight Management

Kiran
KiranNovember 12, 2021
Menopause Menopause: the symptoms, the systems and existing solutions.

Menopause: the symptoms, the systems and existing solutions.

Kiran
KiranAugust 28, 2025
PCOS Ozempic vs Metformin for PCOS: Weighing the treatment options

Ozempic vs Metformin for PCOS: Weighing the treatment options

Kiran
KiranNovember 12, 2021